Financial Performance - The company's operating revenue for 2024 reached CNY 6,017,190,375.67, an increase of 11.30% compared to CNY 5,406,312,590.46 in 2023[21] - The net profit attributable to shareholders of the listed company was CNY 70,884,445.64, a decrease of 82.41% from CNY 403,051,611.99 in the previous year[21] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 62,137,902.01, down 77.72% from CNY 278,858,364.79 in 2023[21] - The net cash flow from operating activities was CNY 419,565,593.23, an increase of 12.65% compared to CNY 372,461,428.84 in 2023[21] - Basic earnings per share decreased by 82.42% to CNY 0.0694 compared to CNY 0.3947 in 2023[22] - Net profit attributable to shareholders decreased by 82.41% due to a decline in gross profit and investment income[22] - The weighted average return on equity decreased by 6.17 percentage points to 1.29% from 7.46% in 2023[22] Assets and Liabilities - The total assets at the end of 2024 were CNY 8,843,999,066.31, a decrease of 1.14% from CNY 8,946,377,928.42 at the end of 2023[21] - The net assets attributable to shareholders of the listed company were CNY 5,505,042,539.52, a slight decrease of 0.28% from CNY 5,520,675,866.70 at the end of 2023[21] - The company reported a net cash outflow from financing activities of ¥496,179,946.71, a significant decrease of 165.34% compared to the previous year, primarily due to increased cash used for debt repayment[46] - The accounts payable increased by 291.84% to ¥255,443,942.00, indicating a rise in external payment obligations[59] Dividends and Shareholder Returns - The company plans to distribute a cash dividend of CNY 0.23 per 10 shares, totaling CNY 23,486,409.98, based on a total share capital of 1,021,148,260 shares[6] - The cash dividend distribution for the year 2023 is set at 0.119 yuan per share, totaling approximately 121.52 million yuan, which represents about 30.15% of the net profit attributable to shareholders[146] - The cumulative cash dividend amount over the last three accounting years is approximately 328.81 million yuan, with a cash dividend ratio of 96.33% based on the average annual net profit[151] Research and Development - The company is committed to high-quality development and innovation as part of its strategic goals for the "14th Five-Year Plan" period[32] - R&D expenses increased by 17.13% to ¥143,898,523.68, primarily due to higher direct material and testing costs associated with R&D projects[46] - Total R&D investment amounted to ¥159,306,758.78, representing 2.65% of operating revenue[54] - The number of R&D personnel is 468, accounting for 11% of the total workforce[55] - The company is actively involved in the research and development of various vaccines, including a rabies inactivated vaccine and a vaccine for pseudorabies in pigs[71] Market and Product Development - The company achieved a significant market share in key products such as foot-and-mouth disease vaccine and ST pig fever vaccine, with a focus on large clients and major products[32] - The company is actively expanding its product offerings in the pet market, integrating various marketing strategies and accelerating product development[34] - The company is expanding its product offerings in pet nutrition and health products[73] - The company plans to expand its international market presence as part of its "Belt and Road" initiative, enhancing competitiveness[100] Corporate Governance and Compliance - The company emphasizes that forward-looking statements in the report do not constitute substantive commitments to investors, highlighting potential investment risks[7] - The company has received a standard unqualified audit report from Tianjian Accounting Firm[5] - The company is committed to enhancing corporate governance and compliance with legal regulations, ensuring no insider trading incidents occurred during the reporting period[112] - The company’s audit committee emphasized the importance of independent and objective auditing practices, contributing to improved corporate governance and internal control[131] Environmental and Social Responsibility - The company invested approximately ¥29.83 million in environmental protection during the reporting period[157] - The company has implemented comprehensive pollution prevention measures, ensuring that all wastewater and waste gas meet discharge standards[160] - Total investment in poverty alleviation and rural revitalization projects amounted to 1.32 million CNY, with 1.1 million CNY allocated for targeted assistance in Xiaoxian County[175] - The company donated a total of 150,000 CNY to charity initiatives, including 100,000 CNY for the "Charity One Day Donation" event in Linyi City[174] Strategic Planning and Future Outlook - The company aims to enhance its position as a leader in the animal health and feed additive industry, focusing on green development and innovation[99] - The company plans to balance traditional industry upgrades with the development of strategic emerging industries to enhance competitiveness and resilience in the supply chain[105] - The company will strengthen risk prevention measures to ensure safety in development and maintain national security responsibilities[107] - The company provided a positive outlook for the next quarter, projecting a revenue increase of 25% to 1.875 billion RMB[119]

中牧股份（600195）公告，2024年营业收入60.17亿元，同比增长11.30%。归属于上市公司股东的净利 润7088.44万元，同比下降82.41%。向全体股东每10股派发现金红利0.23元，共计派发现金红利2348.64 万元。 ...

同意中牧实业股份有限公司 2025 年度投资计划。 二、关于调整、更名公司部分组织机构的议案 表决结果：6 票同意，0 票反对，0 票弃权。 股票代码：600195 股票简称：中牧股份 编号：临 2025-004 中牧实业股份有限公司 第九届董事会 2025 年第四次临时会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 中牧实业股份有限公司（以下简称"公司"）第九届董事会 2025 年第四次临时 会议通知于 2025 年 3 月 24 日通过公司电子办公系统、电子邮件等形式发出，会议 于 2025 年 3 月 27 日以通讯方式召开，会议应到董事 6 名，实到董事 6 名。会议由 董事长吴冬荀先生主持，符合《公司法》《公司章程》的规定。 会议审议并通过以下事项： 一、中牧实业股份有限公司 2025 年度投资计划 表决结果：6 票同意，0 票反对，0 票弃权。 根据公司战略规划和业务经营管理需要，同意成立国际业务发展部，同意将战 略运营部与投资管理部合并，成立战略投资部，同时相应调整部门职责定位；同意 新业务发展部更 ...

股票代码：600195 股票简称：中牧股份 编号：临 2025-003 中牧实业股份有限公司 第九届董事会 2025 年第三次临时会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、关于修订《中牧实业股份有限公司总经理工作细则》部分条款的议案 表决结果：6 票同意，0 票反对，0 票弃权。 本议案已经公司第九届董事会薪酬与考核委员会第一次会议审议通过。 本议案需提交公司股东会审议。 特此公告 中牧实业股份有限公司董事会 中牧实业股份有限公司（以下简称"公司"）第九届董事会 2025 年第三次临时 会议通知于 2025 年 2 月 21 日通过公司电子办公系统、电子邮件等形式发出，会议 于 2025 年 2 月 26 日以通讯方式召开，会议应到董事 6 名，实到董事 6 名。会议由 董事长吴冬荀先生主持，符合《公司法》《公司章程》的规定。 2025 年 2 月 27 日 会议审议并通过以下事项： 同意修订《中牧实业股份有限公司总经理工作细则》部分条款。 二、关于修订原《中牧实业股份有限公司董事、监事、高级管理人员薪 ...

Financial Performance Forecast - The company expects a net profit attributable to shareholders for 2024 to be between 62.51 million and 88.03 million CNY, a decrease of 315.02 million to 340.54 million CNY compared to the previous year, representing a year-on-year decline of 78.16% to 84.49%[3] - The projected net profit excluding non-recurring gains and losses for 2024 is estimated to be between 57.79 million and 83.31 million CNY, down by 195.55 million to 221.07 million CNY from the previous year, reflecting a decrease of 70.12% to 79.28%[3] - In 2023, the total profit was 406.38 million CNY, with a net profit attributable to shareholders of 403.05 million CNY, and a net profit excluding non-recurring gains and losses of 278.86 million CNY[4] Factors Affecting Performance - The decline in performance is attributed to industry overcapacity, reduced profitability in the breeding sector, fluctuating raw material prices, and intensified market competition[5] - The company reported a significant investment income of 143.56 million CNY from the disposal of long-term equity investments in 2023, which will not recur in 2024, contributing to the profit decline[6] Strategic Response - The company is actively responding to multiple pressures by optimizing marketing structures, enhancing marketing efforts, and developing new products and business lines[6] - The company maintains a strong market share and operational stability despite the challenges faced[6] Audit and Investment Caution - The preliminary financial data provided is subject to final audit and may differ from the officially disclosed figures in the 2024 annual report[8] - There are no significant uncertainties affecting the accuracy of this performance forecast[7] - Investors are advised to be cautious regarding investment risks based on the preliminary nature of the forecast data[8]

Core Viewpoint - The company announced a projected net profit for 2024 ranging from 62.51 million to 88.03 million, representing a decrease of 78.16% to 84.49% compared to previous figures [1] Company Summary - The company is facing an industry-wide overcapacity in 2024, leading to a decline in profitability within the aquaculture sector [1] - Raw material prices are expected to fluctuate, and intensified market competition is anticipated to significantly lower production prices [1] - In 2023, the company generated investment income of 144 million from long-term equity investments, but there are no related asset investment activities planned for 2024 [1]

股票代码：600195 股票简称：中牧股份 编号：临 2025-001 中牧实业股份有限公司 第九届董事会 2025 年第一次临时会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 董事会授权公司总经理与相关银行签署公司总部 2025 年度授信项下的协议 及合同文本。 二、关于聘任公司董事会秘书的议案 表决结果：6 票同意，0 票反对，0 票弃权。 同意聘任焦洁女士（简历附后）为公司董事会秘书，任期自本次董事会审议 通过之日起，至公司第九届董事会届满之日止。 焦洁女士的任职资格已经公司第九届董事会提名委员会第一次会议审议通 过。 特此公告 中牧实业股份有限公司（以下简称"公司"）第九届董事会 2025 年第一次临 时会议通知于 2025 年 1 月 6 日通过公司电子办公系统、邮件等形式发出，会议 于 2025 年 1 月 9 日以通讯方式召开，会议应到董事 6 名，实到董事 6 名。符合 《公司法》《公司章程》的规定。 会议审议并通过以下事项： 一、关于申请 2025 年度银行授信额度的议案 表决结果：6 票同意， ...

股票代码：600195 股票简称：中牧股份 编号：临 2024-060 中牧实业股份有限公司 2024 年第六次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 (一) 股东会召开的时间：2024 年 12 月 27 日 (二) 股东会召开的地点：北京市丰台区南四环西路 188 号总部基地 8 区 16 号 楼 8 层公司会议室 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 230 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 519,042,816 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | 50.8293 | | 份总数的比例（%） | | (四) 表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次会议由公司董事会召集，采用现场投票和网络投票相结合的方式召开。 现场会议由董事长吴冬荀先生主 ...

经与会监事审议，会议表决通过如下议案： 关于选举公司第九届监事会主席的议案 表决结果：3 票同意，0 票反对，0 票弃权。 选举侯士忠先生为公司第九届监事会主席，任期为自本次会议通过之日起，至 公司第九届监事会届满之日止。 股票代码：600195 股票简称：中牧股份 编号：临 2024-062 中牧实业股份有限公司 第九届监事会 2024 年第一次临时会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 中牧实业股份有限公司（以下简称"公司"）第九届监事会 2024 年第一次临时 会议通知于 2024 年 12 月 24 日通过公司电子办公系统、电子邮件等形式发出，会 议于 2024 年 12 月 27 日在北京市丰台区南四环西路 188 号总部基地八区 16 号楼公 司会议室召开。会议应到监事 3 名，实到监事 3 名，会议由公司半数以上监事共同 推举监事侯士忠先生主持，符合《公司法》《公司章程》的规定。 1 特此公告 中牧实业股份有限公司监事会 2024 年 12 月 28 日 ...

北京金诚同达律师事务所 关于 中牧实业股份有限公司 2024 年第六次临时股东会的 法律意见书 金证法意 2024 字 1227 第 0747 号 JT&N[金诚同达律师事务所 JINCHENG TONGDA & NEAL LAW FIRM 北京市朝阳区建国门外大街 1 号国贸大厦 A 座 10 层 电话: 010-5706 8585 传真: 010-8515 0267 北京金诚同达律师事务所 法律意见书 北京金诚同达律师事务所 关于 中牧实业股份有限公司 2024 年第六次临时股东会的 本法律意见书系依据《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公司股东大会规 则》（以下简称"《股东大会规则》"）、《上海证券交易所股票上市规则》（以 下简称"《上市规则》"）等法律、法规、规章、规范性文件以及《中牧实业股份 有限公司章程》（以下简称"《公司章程》"）出具。 为出具本法律意见书，本所律师出席了本次股东会，并依照中国现行有效的法 律、法规、规章及规范性文件的要求和规定，对公司提供的与本次股东会有关的文 件、资料进行了审查和验证。 在本法律意见书 ...